Verseon Corporation Directorate Change (3411O)

TIDMVSN

RNS Number : 3411O

Verseon Corporation

29 January 2019

January 29, 2019

Verseon Corporation

("Verseon" or the "Company")

Directorate change

Fremont, Calif.--Verseon Corporation (AIM:VSN), a technology-based pharmaceutical company, announces that Xavier Rolet, on account of his recent executive appointment, will be stepping down from his role as a non-executive director on February 23, 2019 in order to avoid any potential conflicts with Verseon and its subsidiaries' businesses.

"We thank Xavier for his contribution and wish him every success in his new role," said Adityo Prakash, CEO of Verseon.

About Verseon

Verseon Corporation (www.verseon.com, AIM: VSN) is developing disruptive life-science technology to advance global health. The clinical-stage company is using its proprietary, computational drug discovery platform paired with a comprehensive in-house chemistry and biology workflow to build a growing drug development pipeline. Through its wholly owned subsidiary BlockRules Ltd., Verseon is also pioneering blockchain technology for regulated securities.

-Ends-

For further information, please contact

 
 Verseon Corporation                        www.verseon.com 
                                               +1 (510) 225 
 Sebastian Wykeham / Tina Schlafly                     9000 
 
 Arden Partners (NOMAD and Joint Broker) 
                                                 +44 (0) 20 
 Ruari McGirr / Ciaran Walsh                      7614 5900 
 
 Cantor Fitzgerald Europe (Joint Broker) 
                                            +44 (0) 20 7894 
 Phil Davies                                           7000

For financial and business media enquiries, please contact

 
 Buchanan Communications Ltd (PR Advisers) 
                                              +44 (0) 20 7466 
 Henry Harrison-Topham / Jamie Hooper                    5000

For trade and pharma media enquiries, please contact

 
 Vane Percy & Roberts 
                         +44 (0) 1737 
 Simon Vane Percy             821 890

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BOAMMGZMMLNGLZG

(END) Dow Jones Newswires

January 29, 2019 02:00 ET (07:00 GMT)

Verseon (LSE:VSN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024